Loading…
Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation
To investigate the dynamic features of insulin-like growth factor-I receptor (IGF-IR) expression in rat hepatocarcinogenesis, and the relationship between IGF-IR and hepatocytes malignant transformation at mRNA or protein level. Hepatoma models were made by inducing with 2-fluorenylacetamide (2-FAA)...
Saved in:
Published in: | World journal of gastroenterology : WJG 2013-09, Vol.19 (36), p.6084-6092 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c396t-984a96fe430b5f7c111220c1d7a891165050028c8db6b1ec266eae7c83a405de3 |
---|---|
cites | |
container_end_page | 6092 |
container_issue | 36 |
container_start_page | 6084 |
container_title | World journal of gastroenterology : WJG |
container_volume | 19 |
creator | Yan, Xiao-Di Yao, Min Wang, Li Zhang, Hai-Jian Yan, Mei-Juan Gu, Xing Shi, Yun Chen, Jie Dong, Zhi-Zhen Yao, Deng-Fu |
description | To investigate the dynamic features of insulin-like growth factor-I receptor (IGF-IR) expression in rat hepatocarcinogenesis, and the relationship between IGF-IR and hepatocytes malignant transformation at mRNA or protein level.
Hepatoma models were made by inducing with 2-fluorenylacetamide (2-FAA) on male Sprague-Dawley rats. Morphological changes of hepatocytes were observed by pathological Hematoxylin and eosin staining, the dynamic expressions of liver and serum IGF-IR were quantitatively analyzed by an enzyme-linked immunosorbent assay. The distribution of hepatic IGF-IR was located by immunohistochemistry. The fragments of IGF-IR gene were amplified by reverse transcription-polymerase chain reaction, and confirmed by sequencing.
Rat hepatocytes after induced by 2-FAA were changed dynamically from granule-like degeneration, precancerous to hepatoma formation with the progressing increasing of hepatic mRNA or IGF-IR expression. The incidences of liver IGF-IR, IGF-IR mRNA, specific IGF-IR concentration (ng/mg wet liver), and serum IGF-IR level (ng/mL) were 0.0%, 0.0%, 0.63 ± 0.17, and 1.33 ± 0.47 in the control; 50.0%, 61.1%, 0.65 ± 0.2, and 1.51 ± 0.46 in the degeneration; 88.9%, 100%, 0.66 ± 0.14, and 1.92 ± 0.29 in the precancerosis; and 100%, 100%, 0.96 ± 0.09, and 2.43 ± 0.57 in the cancerous group, respectively. IGF-IR expression in the cancerous group was significantly higher (P < 0.01) than that in any of other groups at mRNA or protein level. The closely positive IGF-IR relationship was found between livers and sera (r = 0.91, t = 14.222, P < 0.01), respectively.
IGF-IR expression may participate in rat hepatocarcinogenesis and its abnormality should be an early marker for hepatocytes malignant transformation. |
doi_str_mv | 10.3748/wjg.v19.i36.6084 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3785631</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>24106410</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-984a96fe430b5f7c111220c1d7a891165050028c8db6b1ec266eae7c83a405de3</originalsourceid><addsrcrecordid>eNpVkctKAzEUhoMotlb3riQvMDWXmUxmI0jxBkI3ug6Z9EybdjoZkrRV3LjxRX0SI17QxSEc_vz_OcmH0CklY17m8ny3nI-3tBpbLsaCyHwPDRmjVcZkTvbRkBJSZhVn5QAdhbAkhHFesEM0YDklItUQvUy34OGp9xCCdR12DbZd2LS2y1q7Ajz3bhcXuNEmOp_dvb--eTDQpwbrgDXuwUfbQRdxbd1a-xV43CRxAb2OzjxHCHitWzvvdLoTve5Cktc6pmHH6KDRbYCT73OEHq-vHia32f305m5yeZ8ZXomYVTLXlWgg56QumtJQShkjhs5KLStKRUGK9DJp5KwWNQXDhAANpZFc56SYAR-hi6_cflOvYWbStl63qvc2LfysnLbqv9LZhZq7reKlLASnKYB8BRjvQvDQ_HopUZ8gVAKhEgiVQKhPEMly9nfmr-Hn5_kHkA6LWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation</title><source>PubMed Central</source><creator>Yan, Xiao-Di ; Yao, Min ; Wang, Li ; Zhang, Hai-Jian ; Yan, Mei-Juan ; Gu, Xing ; Shi, Yun ; Chen, Jie ; Dong, Zhi-Zhen ; Yao, Deng-Fu</creator><creatorcontrib>Yan, Xiao-Di ; Yao, Min ; Wang, Li ; Zhang, Hai-Jian ; Yan, Mei-Juan ; Gu, Xing ; Shi, Yun ; Chen, Jie ; Dong, Zhi-Zhen ; Yao, Deng-Fu</creatorcontrib><description>To investigate the dynamic features of insulin-like growth factor-I receptor (IGF-IR) expression in rat hepatocarcinogenesis, and the relationship between IGF-IR and hepatocytes malignant transformation at mRNA or protein level.
Hepatoma models were made by inducing with 2-fluorenylacetamide (2-FAA) on male Sprague-Dawley rats. Morphological changes of hepatocytes were observed by pathological Hematoxylin and eosin staining, the dynamic expressions of liver and serum IGF-IR were quantitatively analyzed by an enzyme-linked immunosorbent assay. The distribution of hepatic IGF-IR was located by immunohistochemistry. The fragments of IGF-IR gene were amplified by reverse transcription-polymerase chain reaction, and confirmed by sequencing.
Rat hepatocytes after induced by 2-FAA were changed dynamically from granule-like degeneration, precancerous to hepatoma formation with the progressing increasing of hepatic mRNA or IGF-IR expression. The incidences of liver IGF-IR, IGF-IR mRNA, specific IGF-IR concentration (ng/mg wet liver), and serum IGF-IR level (ng/mL) were 0.0%, 0.0%, 0.63 ± 0.17, and 1.33 ± 0.47 in the control; 50.0%, 61.1%, 0.65 ± 0.2, and 1.51 ± 0.46 in the degeneration; 88.9%, 100%, 0.66 ± 0.14, and 1.92 ± 0.29 in the precancerosis; and 100%, 100%, 0.96 ± 0.09, and 2.43 ± 0.57 in the cancerous group, respectively. IGF-IR expression in the cancerous group was significantly higher (P < 0.01) than that in any of other groups at mRNA or protein level. The closely positive IGF-IR relationship was found between livers and sera (r = 0.91, t = 14.222, P < 0.01), respectively.
IGF-IR expression may participate in rat hepatocarcinogenesis and its abnormality should be an early marker for hepatocytes malignant transformation.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v19.i36.6084</identifier><identifier>PMID: 24106410</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Co., Limited</publisher><subject>2-Acetylaminofluorene ; Animals ; Biomarkers, Tumor - blood ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Brief ; Carcinoma, Hepatocellular - chemically induced ; Carcinoma, Hepatocellular - genetics ; Carcinoma, Hepatocellular - metabolism ; Carcinoma, Hepatocellular - pathology ; Cell Transformation, Neoplastic - chemically induced ; Cell Transformation, Neoplastic - genetics ; Cell Transformation, Neoplastic - metabolism ; Cell Transformation, Neoplastic - pathology ; Disease Models, Animal ; Gene Expression Regulation, Neoplastic ; Hepatocytes - metabolism ; Hepatocytes - pathology ; Liver Neoplasms - chemically induced ; Liver Neoplasms - genetics ; Liver Neoplasms - metabolism ; Liver Neoplasms - pathology ; Male ; Rats ; Rats, Sprague-Dawley ; Receptor, IGF Type 1 - blood ; Receptor, IGF Type 1 - genetics ; Receptor, IGF Type 1 - metabolism ; RNA, Messenger - metabolism ; Up-Regulation</subject><ispartof>World journal of gastroenterology : WJG, 2013-09, Vol.19 (36), p.6084-6092</ispartof><rights>2013 Baishideng Publishing Group Co., Limited. All rights reserved. 2013</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-984a96fe430b5f7c111220c1d7a891165050028c8db6b1ec266eae7c83a405de3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785631/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785631/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24106410$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yan, Xiao-Di</creatorcontrib><creatorcontrib>Yao, Min</creatorcontrib><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Zhang, Hai-Jian</creatorcontrib><creatorcontrib>Yan, Mei-Juan</creatorcontrib><creatorcontrib>Gu, Xing</creatorcontrib><creatorcontrib>Shi, Yun</creatorcontrib><creatorcontrib>Chen, Jie</creatorcontrib><creatorcontrib>Dong, Zhi-Zhen</creatorcontrib><creatorcontrib>Yao, Deng-Fu</creatorcontrib><title>Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation</title><title>World journal of gastroenterology : WJG</title><addtitle>World J Gastroenterol</addtitle><description>To investigate the dynamic features of insulin-like growth factor-I receptor (IGF-IR) expression in rat hepatocarcinogenesis, and the relationship between IGF-IR and hepatocytes malignant transformation at mRNA or protein level.
Hepatoma models were made by inducing with 2-fluorenylacetamide (2-FAA) on male Sprague-Dawley rats. Morphological changes of hepatocytes were observed by pathological Hematoxylin and eosin staining, the dynamic expressions of liver and serum IGF-IR were quantitatively analyzed by an enzyme-linked immunosorbent assay. The distribution of hepatic IGF-IR was located by immunohistochemistry. The fragments of IGF-IR gene were amplified by reverse transcription-polymerase chain reaction, and confirmed by sequencing.
Rat hepatocytes after induced by 2-FAA were changed dynamically from granule-like degeneration, precancerous to hepatoma formation with the progressing increasing of hepatic mRNA or IGF-IR expression. The incidences of liver IGF-IR, IGF-IR mRNA, specific IGF-IR concentration (ng/mg wet liver), and serum IGF-IR level (ng/mL) were 0.0%, 0.0%, 0.63 ± 0.17, and 1.33 ± 0.47 in the control; 50.0%, 61.1%, 0.65 ± 0.2, and 1.51 ± 0.46 in the degeneration; 88.9%, 100%, 0.66 ± 0.14, and 1.92 ± 0.29 in the precancerosis; and 100%, 100%, 0.96 ± 0.09, and 2.43 ± 0.57 in the cancerous group, respectively. IGF-IR expression in the cancerous group was significantly higher (P < 0.01) than that in any of other groups at mRNA or protein level. The closely positive IGF-IR relationship was found between livers and sera (r = 0.91, t = 14.222, P < 0.01), respectively.
IGF-IR expression may participate in rat hepatocarcinogenesis and its abnormality should be an early marker for hepatocytes malignant transformation.</description><subject>2-Acetylaminofluorene</subject><subject>Animals</subject><subject>Biomarkers, Tumor - blood</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Brief</subject><subject>Carcinoma, Hepatocellular - chemically induced</subject><subject>Carcinoma, Hepatocellular - genetics</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Cell Transformation, Neoplastic - chemically induced</subject><subject>Cell Transformation, Neoplastic - genetics</subject><subject>Cell Transformation, Neoplastic - metabolism</subject><subject>Cell Transformation, Neoplastic - pathology</subject><subject>Disease Models, Animal</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Hepatocytes - metabolism</subject><subject>Hepatocytes - pathology</subject><subject>Liver Neoplasms - chemically induced</subject><subject>Liver Neoplasms - genetics</subject><subject>Liver Neoplasms - metabolism</subject><subject>Liver Neoplasms - pathology</subject><subject>Male</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptor, IGF Type 1 - blood</subject><subject>Receptor, IGF Type 1 - genetics</subject><subject>Receptor, IGF Type 1 - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>Up-Regulation</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpVkctKAzEUhoMotlb3riQvMDWXmUxmI0jxBkI3ug6Z9EybdjoZkrRV3LjxRX0SI17QxSEc_vz_OcmH0CklY17m8ny3nI-3tBpbLsaCyHwPDRmjVcZkTvbRkBJSZhVn5QAdhbAkhHFesEM0YDklItUQvUy34OGp9xCCdR12DbZd2LS2y1q7Ajz3bhcXuNEmOp_dvb--eTDQpwbrgDXuwUfbQRdxbd1a-xV43CRxAb2OzjxHCHitWzvvdLoTve5Cktc6pmHH6KDRbYCT73OEHq-vHia32f305m5yeZ8ZXomYVTLXlWgg56QumtJQShkjhs5KLStKRUGK9DJp5KwWNQXDhAANpZFc56SYAR-hi6_cflOvYWbStl63qvc2LfysnLbqv9LZhZq7reKlLASnKYB8BRjvQvDQ_HopUZ8gVAKhEgiVQKhPEMly9nfmr-Hn5_kHkA6LWA</recordid><startdate>20130928</startdate><enddate>20130928</enddate><creator>Yan, Xiao-Di</creator><creator>Yao, Min</creator><creator>Wang, Li</creator><creator>Zhang, Hai-Jian</creator><creator>Yan, Mei-Juan</creator><creator>Gu, Xing</creator><creator>Shi, Yun</creator><creator>Chen, Jie</creator><creator>Dong, Zhi-Zhen</creator><creator>Yao, Deng-Fu</creator><general>Baishideng Publishing Group Co., Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20130928</creationdate><title>Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation</title><author>Yan, Xiao-Di ; Yao, Min ; Wang, Li ; Zhang, Hai-Jian ; Yan, Mei-Juan ; Gu, Xing ; Shi, Yun ; Chen, Jie ; Dong, Zhi-Zhen ; Yao, Deng-Fu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-984a96fe430b5f7c111220c1d7a891165050028c8db6b1ec266eae7c83a405de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>2-Acetylaminofluorene</topic><topic>Animals</topic><topic>Biomarkers, Tumor - blood</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Brief</topic><topic>Carcinoma, Hepatocellular - chemically induced</topic><topic>Carcinoma, Hepatocellular - genetics</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Cell Transformation, Neoplastic - chemically induced</topic><topic>Cell Transformation, Neoplastic - genetics</topic><topic>Cell Transformation, Neoplastic - metabolism</topic><topic>Cell Transformation, Neoplastic - pathology</topic><topic>Disease Models, Animal</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Hepatocytes - metabolism</topic><topic>Hepatocytes - pathology</topic><topic>Liver Neoplasms - chemically induced</topic><topic>Liver Neoplasms - genetics</topic><topic>Liver Neoplasms - metabolism</topic><topic>Liver Neoplasms - pathology</topic><topic>Male</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptor, IGF Type 1 - blood</topic><topic>Receptor, IGF Type 1 - genetics</topic><topic>Receptor, IGF Type 1 - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>Up-Regulation</topic><toplevel>online_resources</toplevel><creatorcontrib>Yan, Xiao-Di</creatorcontrib><creatorcontrib>Yao, Min</creatorcontrib><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Zhang, Hai-Jian</creatorcontrib><creatorcontrib>Yan, Mei-Juan</creatorcontrib><creatorcontrib>Gu, Xing</creatorcontrib><creatorcontrib>Shi, Yun</creatorcontrib><creatorcontrib>Chen, Jie</creatorcontrib><creatorcontrib>Dong, Zhi-Zhen</creatorcontrib><creatorcontrib>Yao, Deng-Fu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yan, Xiao-Di</au><au>Yao, Min</au><au>Wang, Li</au><au>Zhang, Hai-Jian</au><au>Yan, Mei-Juan</au><au>Gu, Xing</au><au>Shi, Yun</au><au>Chen, Jie</au><au>Dong, Zhi-Zhen</au><au>Yao, Deng-Fu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World J Gastroenterol</addtitle><date>2013-09-28</date><risdate>2013</risdate><volume>19</volume><issue>36</issue><spage>6084</spage><epage>6092</epage><pages>6084-6092</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>To investigate the dynamic features of insulin-like growth factor-I receptor (IGF-IR) expression in rat hepatocarcinogenesis, and the relationship between IGF-IR and hepatocytes malignant transformation at mRNA or protein level.
Hepatoma models were made by inducing with 2-fluorenylacetamide (2-FAA) on male Sprague-Dawley rats. Morphological changes of hepatocytes were observed by pathological Hematoxylin and eosin staining, the dynamic expressions of liver and serum IGF-IR were quantitatively analyzed by an enzyme-linked immunosorbent assay. The distribution of hepatic IGF-IR was located by immunohistochemistry. The fragments of IGF-IR gene were amplified by reverse transcription-polymerase chain reaction, and confirmed by sequencing.
Rat hepatocytes after induced by 2-FAA were changed dynamically from granule-like degeneration, precancerous to hepatoma formation with the progressing increasing of hepatic mRNA or IGF-IR expression. The incidences of liver IGF-IR, IGF-IR mRNA, specific IGF-IR concentration (ng/mg wet liver), and serum IGF-IR level (ng/mL) were 0.0%, 0.0%, 0.63 ± 0.17, and 1.33 ± 0.47 in the control; 50.0%, 61.1%, 0.65 ± 0.2, and 1.51 ± 0.46 in the degeneration; 88.9%, 100%, 0.66 ± 0.14, and 1.92 ± 0.29 in the precancerosis; and 100%, 100%, 0.96 ± 0.09, and 2.43 ± 0.57 in the cancerous group, respectively. IGF-IR expression in the cancerous group was significantly higher (P < 0.01) than that in any of other groups at mRNA or protein level. The closely positive IGF-IR relationship was found between livers and sera (r = 0.91, t = 14.222, P < 0.01), respectively.
IGF-IR expression may participate in rat hepatocarcinogenesis and its abnormality should be an early marker for hepatocytes malignant transformation.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Co., Limited</pub><pmid>24106410</pmid><doi>10.3748/wjg.v19.i36.6084</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2013-09, Vol.19 (36), p.6084-6092 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3785631 |
source | PubMed Central |
subjects | 2-Acetylaminofluorene Animals Biomarkers, Tumor - blood Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Brief Carcinoma, Hepatocellular - chemically induced Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - pathology Cell Transformation, Neoplastic - chemically induced Cell Transformation, Neoplastic - genetics Cell Transformation, Neoplastic - metabolism Cell Transformation, Neoplastic - pathology Disease Models, Animal Gene Expression Regulation, Neoplastic Hepatocytes - metabolism Hepatocytes - pathology Liver Neoplasms - chemically induced Liver Neoplasms - genetics Liver Neoplasms - metabolism Liver Neoplasms - pathology Male Rats Rats, Sprague-Dawley Receptor, IGF Type 1 - blood Receptor, IGF Type 1 - genetics Receptor, IGF Type 1 - metabolism RNA, Messenger - metabolism Up-Regulation |
title | Overexpression of insulin-like growth factor-I receptor as a pertinent biomarker for hepatocytes malignant transformation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T08%3A23%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overexpression%20of%20insulin-like%20growth%20factor-I%E2%80%85receptor%20as%20a%20pertinent%20biomarker%20for%20hepatocytes%20malignant%20transformation&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Yan,%20Xiao-Di&rft.date=2013-09-28&rft.volume=19&rft.issue=36&rft.spage=6084&rft.epage=6092&rft.pages=6084-6092&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v19.i36.6084&rft_dat=%3Cpubmed_cross%3E24106410%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c396t-984a96fe430b5f7c111220c1d7a891165050028c8db6b1ec266eae7c83a405de3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/24106410&rfr_iscdi=true |